Behavioral, neuroendocrine and biochemical effects of different doses of 5-HTP in panic disorder

European Neuropsychopharmacology

Volumn 6, Issue 2, 1996, Pages 103-110

  Van Vliet, Irene M ^a   Slaap, Bernhard R ^a   Westenberg, Herman G M ^a   Den Boer, Johan A ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

5 HT receptor sensitivity; 5 Hydroxytryptophan challenge test; Panic disorder

Indexed keywords

5 HYDROXYTRYPTOPHAN; HYDROCORTISONE; SEROTONIN;

ADULT; ANXIETY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; FATIGUE; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NAUSEA; PANIC; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL;

EID: 0029931679     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0924-977X(95)00070-6     Document Type: Article

References (42)

1. American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders, third edition revised. APA, Washinghton, DC.
2. Apostolopoulos, M., Judd, F.K., Burrows, G.D. and Norman, T.R. (1993) Prolactin response to DL-fenfluramine in panic disorder. Psychoneuroendocrinology 18, 337-342.
3. Charney, D.S. and Heninger, G.R. (1986) Serotonin function in panic disorder. The effects of intravenous tryptophan in healthy subjects and patients with panic disorder before and after alprazolam treatment. Arch. Gen. Psychiatry 43, 1059-1065.
4. Charney, D.S., Woods, S.W., Goodman, W.K. and Heninger, G.R. (1987) Serotonin function in anxiety II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects. Psychopharmacology 92, 14-24.
5. Cowen, P.J. (1994) The effect of tryptophan on brain 5HT function: a review. Hum. Psychopharmacol. 9. 371-376.
6. Den Boer, J.A., Westenberg, H.G.M. and Kamerbeek, W.D.J. (1987) Effect of serotonin uptake inhibitors in anxiety disorders, a double-blind comparison of clomipramine and fluvoxamine. Int. Clin. Psychopharmacol. 2, 21-32.
7. Den Boer, J.A. and Westenberg, H.G.M, (1988) Effect of a serotonin and noradrenaline uptake inhibitor in panic disorder, a double-blind comparative study with fluvoxamine and maprotiline. Int. Clin. Psychopharmacol. 3, 59-74.
8. Den Boer, J.A. and Westenberg, H.G.M. (1990a) Serotonin function in panic disorder: a double-blind placebo controlled study with fluvoxamine and ritanserin. Psychopharmacology 102, 85-93.
9. Den Boer, J.A. and Westenberg, H.G.M. (1990b) Behavioral, neuroendocrine and biochemical effects of 5-HTP administration in panic disorder. Psychiatry Res. 31, 267-278.
10. Dillon, D.J., Gorman, J.M. and Liebowitz, M.R. (1987) Measurement of lactate-induced panic and anxiety. Psychiatry Res. 20, 97-105.
11. Evans, L., Kenardy, J., Schneider, P. and Hoey, H. (1986) Effect of a selective serotonin uptake inhibitor in agoraphobia with panic attacks. Acta Psychiatr. Scand. 73, 49-50.
12. Fuller, W. (1990) Serotonin receptors and neuroendocrin responses. Neuropsychopharmacology 3, 495.
13. 2 receptors. Eur. J. Pharmacol. 179, 103-109.
14. Gartside, S.E., Cowen, P.J. and Sharp, T. (1992) Effect of 5-hydroxy-L-tryptophan on the release of 5-HT in rat hypothalamus in vivo as measured by microdialysis. Neuropharmacology 31, 9-14.
15. Germine, M., Goddard, A.W., Sholomskas, D.E., Woods, S.W., Charney, D.S. and Heninger, G.R. (1994) Response to meta-chlorophenylpiperazine in panic disorder patients and healthy subjects: influence of reduction in intravenous dosage. Psychiatry Res. 54. 115-134.
16. Goodall, E.M., Cowen, P.J., Franklin, M. and Silverstone, T. (1993) Ritanserin attenuates anorectic, endocrine and thermic responses to D-fenfluramine in human volunteers. Psychopharmacology 112, 461-466.
17. Hamilton, M. (1960) A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23, 56-62.
18. Johnston, D.G., Troyer, I.E. and Whitstett, S.F. (1988) Clomipramine in the treatment of agoraphobic women. An eight week controlled trial. Arch. Gen. Psychiatry 45, 453-459.
19. Judd, F.K., Apostolopoulos, M., Burrows, G.D. and Norman, T.R. (1994) Serotonergic function in panic disorder: endocrine responses to D-fenfluramine, Prog. Neuro-Psychopharmacol. Biol. Psychiatry 18, 329-337.
20. Kahn, R.S. and Westenberg, H.G.M. (1985) L-5-hydroxytryptophan in the treatment of anxiety disorders. J. Affect. Disord, 8, 197-200.
21. Kahn, R.S., Asnis, G.M., Wetzler, S. and Van Praag, H.M. (1988a) Neuroendocrine evidence for serotonin hypersensitivity in panic-disorder. Psychopharmacology 96, 360-364.
22. Kahn, R.S., Wetzler, S., Van Praag, H.M. and Asnis, G.M. (1988b) Behavioural indications of a serotonergic supersensitivity in panic disorder. Psychiatry Res. 25, 101-104.
23. Kalus, O., Kahn, R.S., Wetzler, S., Asnis, G.M. and Van Praag, H.M. (1991) Behavioral hypersensitivity to m-chlorophenylpiperazine in a subject with subclinical panic attacks. Biol. Psychiatry 28, 1053-1057.
24. Klein, E., Zohar, J., Geraci, M.F., Murphy, D.L. and Uhde, T.W. (1991) Anxiogenic effects of m-CPP in patients with panic disorder-comparison to caffeine's anxiogenic effects. Biol. Psychiatry 30, 973-984.
25. Lee, M.A., Nash, J.F., Barnes, M. and Meltzer, H.Y. (1991) Inhibitory effects of ritanserin on the 5-hydroxytryptophan-mediated cortisol, ACTH and prolactin secretion in humans. Psychopharmacology 103, 258.
26. Lesch, K.P. (1991) 5-HT-1A receptor responsivity in anxiety disorder and depression. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 15, 723-733.
27. Lesch, K.P., Wiesmann, M., Hoh, A., MÜller, T., Disselkamp-Tietze, J., Osterheider, M. and Schulte, H.M. (1992) 5-HT-1A receptor-effector system responsivity in panic disorder. Psychopharmacology 106, 111-117.
28. Liebowitz, M.R., Fyer, A.J. and Gorman, J.M. (1984) Lactate provocation of panic attacks. I. Clinical and behavioural findings. Arch. Gen. Psychiatry 41, 764-770.
29. Linden, M. and Krautzig, E. (1981) Befindlichkeitsmessung in kurzzeitigen Abstanden: ein experimenteller Beitrag zur Invalidierung der Befindlichkeitsskala (Bf-S) nach Von Zerssen. Pharmakopsychiatrie 14, 40-41.
30. McNair, D.M., Lorr, M. abd Droppelman, L.F. (1971) Manual for the Profile of Mood States. Educational and Industrial Testing Service, San Diego, CA.
31. O'Brien, R.G. and Kaiser, M.K. (1985) MANOVA method for analysing repeated measures designs: An extensive primer. Psychol. Bull. 97, 316-333.
32. Peroutka, S.J. and Snyder, S.H. (1980) Long-term antidepressant treatment decreases spiroperodol-labelled serotonin receptor binding. Science 210, 88-90.
33. Quattrone, A., Tedeschi, G., Aguglia, U., Scopacasa, R. and Direnzo, G. (1983) Prolactin secretion in man: a usefool tool to evaluate the activity of drugs on central 5-hydroxytryptaminergic neurones, studies with fenfluramine. Br. J. Clin. Pharmacol. 16, 471-475.
34. Rausch, J.L., Stahl, S.M. and Hauger, R.L. (1990) Cortisol and growth hormone response to the 5-HT-1A agonist gepirone in depressed patients. Biol. Psychiatry 28, 73-78.
35. Rowland, N.E. and Carlton, J. (1986) Neurobiology of an anorectic drug: fenfluramine. Prog. Neurobiol. 27, 13-62.
36. Seibyl, J.P., Krystal, J.H., Price, L.H., Woods, S.W., D'Amico, C., Heninger, G.R. and Charney, D.S. (1991) Effects of ritanserin on the behavioural, neuroendocrine and cardiovascular responses to metachlorophenylpiperazine in healthy human subjects. Psychiatry Res. 38, 227-236.
37. Seletti, B., Benkelfat, C., Blier, P., Gilbert, F., Dean, P. and De Montigny, C. (1993) Antagonism of the hypothermie and endocrine effects of i.v. flesinoxan in humans. Biol. Psychiatry 33, 156A.
38. Targum, S.D. and Marshall, L.E. (1989) Fenfluramine provocation of anxiety in patients with panic disorder. Psychiatr. Res. 28, 295-306.
39. Thijssen, J.H.H., Van den Berg, J.H.M. and Adlerkreutz, J. (1980) The determination of cortisol in human plasma: evaluation and comparison of seven assays. Clin. Chim. Acta 100, 39-46.
40. Van Vliet, I.M., Den Boer, J.A., Westenberg, H.G.M. and Slaap, B.R. (1995) A double blind placebo controlled comparative study of brofaromine and fluvoxamine in panic disorder. Submitted for publication.
41. Westenberg, H.G.M., Gerritsen, T.W. and Meijer, B.A. (1982) Kinetics of L-5-hydroxytryptophan in healthy subjects. Psychiatry Res. 7, 373-383.
42. Von Zerssen, D. (1986) Clinical self-ratings scales (CSRS) of the Munich Psychiatric Information System. In: N. Sartorius and T.A. Ban (Eds.), Assessment of Depression. Springer Verlag, Berlin, pp. 270-303.